Five outbreaks of African swine fever in pigs reported in Poland this year, says ministry
WARSAW (Reuters) - Five outbreaks of African Swine Fever in pigs have been reported in Poland so far this year, the agriculture ministry said on Tuesday. The outbreaks were reported in four regions: Lubelskie, Warminsko-Mazurskie, Wielkopolskie and...
Jun 11, 2024
Sage Therapeutics' rare disease drug meets main goal in mid-stage study
(Reuters) - Sage Therapeutics said on Tuesday its experimental drug met the main goal of a mid-stage study in patients with a type of rare disease known as Huntington's disease. (Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)
Jun 11, 2024
Latest trial over Zantac cancer claims called off as plaintiff drops case
By Brendan Pierson (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announce...
Jun 10, 2024
Eli Lilly exec expects obesity pill data in April 2025
(Reuters) - Data from Eli Lilly's late stage trial on experimental obesity pill orforglipron is expected in April 2025, a top Eli Lilly executive said on Monday. The pill is part of a class of drugs known as incretins designed to mimic the action o...
Jun 10, 2024
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
(Reuters) -The U.S. Food and Drug Administration has granted accelerated approval French drugmakers Ipsen and Genfit's drug to treat a chronic inflammatory liver disease, Ipsen said on Monday. Primary biliary cholangitis (PBC) causes inflammation of th...
Jun 10, 2024
Eli Lilly exec says seeing out of pocket payments for obesity drug in US
(Reuters) - A top Eli Lilly executive said on Monday that more patients are paying the full list price of its obesity drug Zepbound than those who had paid for its predecessor Mounjaro. Patrik Jonsson, President of Lilly Diabetes and Obesity, speak...
Jun 10, 2024
U.S. unveils new task force aimed at cracking down on illicit e-cigarettes
By Sarah N. Lynch WASHINGTON (Reuters) - The U.S. Justice Department and the Food and Drug Administration on Monday launched a new task force that will take aim at the sale and distribution of illicit e-cigarettes, in a move to protect youth from i...
Jun 10, 2024
Dsm-firmenich sees boost as weight-loss drugs spur healthier choices
By Dimitri Rhodes and Matteo Allievi (Reuters) - The soaring popularity of weight-loss drugs are likely to spur demand for dietary supplements and healthier food formulations, creating growth opportunities for dsm-firmenich, the CEO of the flavour...
Jun 10, 2024
Canada, UK launched joint probe into 23andMe data breach, says Canada
OTTAWA (Reuters) - The Canadian and British privacy authorities have launched a joint probe into a data breach at genetics testing company 23andme last year, Canada's privacy commissioner said in a statement on Monday. Last October, 23andMe told so...
Jun 10, 2024
US FDA clears Abbott's continuous glucose monitors for over-the-counter use
(Reuters) -Abbott said on Monday that the U.S. Food and Drug Administration has cleared its two continuous glucose monitoring systems for over-the-counter use. One of the devices, known as Lingo, is a consumer biowearable, designed for consumers 18 yea...
Jun 10, 2024
EU to secure 40 million avian flu vaccines for 15 countries - officials
By Julia Payne BRUSSELS (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday. The deal secur...
Jun 10, 2024
Skye Bioscience to stop eye disease drug development after failing mid-stage study
(Reuters) -Skye Bioscience said on Monday it would discontinue development of its experimental eye disease treatment after the drug failed to meet the main goal of a mid-stage study, dragging its shares down 41%. The eye drop, SBI-100, failed to lower ...
Jun 10, 2024
US FDA advisers to review Eli Lilly Alzheimer's drug
By Bhanvi Satija and Julie Steenhuysen (Reuters) - An independent advisory panel to the U.S. Food and Drug Administration will vote later on Monday on the safety and effectiveness of Eli Lilly's experimental Alzheimer's drug donanemab. Donanemab, i...
Jun 10, 2024
Moderna COVID/flu combo vaccine superior to separate shots in trial
By Patrick Wingrove (Reuters) - Moderna said on Monday its combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults aged 50 and over when compared to separate shots against the viruses in a ...
Jun 10, 2024
Added health benefits of Wegovy, Zepbound could attract more men, doctors say
By Bhanvi Satija and Sriparna Roy (Reuters) - Evidence that weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound can cut heart disease risk, treat sleep apnea and address other health issues may help convince more men to use them,...
Jun 10, 2024
Indonesia ramps up fight against tuberculosis amid concerns on economic impact
JAKARTA (Reuters) - Indonesia plans to run clinical trials of several vaccines to fight surging cases of tuberculosis (TB) this year, with concerns the disease might affect economic growth, ministers said on Monday. The Southeast Asian country has ...
Jun 10, 2024
Olympic athletes turn to diabetes tech in pursuit of medals
By Ludwig Burger (Reuters) - Olympians including Dutch marathon runner Abdi Nageeye are using a new tool they hope will boost their medal chances this summer: tiny monitors that attach to the skin to track blood glucose levels. Continuous glucose m...
Jun 10, 2024
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
By Sriparna Roy and Christy Santhosh (Reuters) -The U.S. Food and Drug Administration approved the expanded use of GSK's respiratory syncytial virus (RSV) vaccine on Friday in adults aged between 50 and 59, making it the first shot endorsed for that a...
Jun 07, 2024
WHO says first human case of avian influenza A (H5N1) reported in Australia
(Reuters) - The World Health Organization on Friday said the first laboratory-confirmed case of human infection with avian influenza A (H5N1) virus was reported in Australia. (Reporting by Nilutpal Timsina in Bengaluru; editing by Jonathan Oatis)
Jun 07, 2024
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
By Michael Erman (Reuters) - A 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according a study by Stanford University researchers. Currently, there are no proven treatments specifically for ...
Jun 07, 2024
US to research possible respiratory spread of bird flu in cows
By Leah Douglas, P.J. Huffstutter and Julie Steenhuysen (Reuters) - U.S. federal and state agencies are planning research into potential respiratory spread of bird flu among dairy cattle, according to a Reuters interview with Michigan state agricul...
Jun 07, 2024
Waystar shares fall 2% in underwhelming Nasdaq debut
(Reuters) -Shares of Waystar fell 2.3% below their initial public offering price in their Nasdaq Global Select Market debut on Friday, giving the healthcare payments company a valuation of $3.50 billion. The company's stock opened at $21, slightly belo...
Jun 07, 2024
J&J-backed Rapport Therapeutics valued at $636.8 million after shares rise 6% in debut
(Reuters) - Shares of Rapport Therapeutics, backed by Johnson & Johnson's venture capital arm, rose nearly 6% in their market debut on Friday, valuing the early stage therapy developer at $636.8 million. The U.S. initial public offering market is s...
Jun 07, 2024
COVID shots should target JN.1 variants in 2024-25 campaign, US FDA says
(Reuters) - The U.S. Food and Drug Administration on Friday advised COVID-19 vaccine manufacturers that new shots for the fall 2024 campaign should target the JN.1 variant that was dominant earlier this year. (Reporting by Leroy Leo in Bengaluru; ...
Jun 07, 2024
Mexico health ministry: bird flu patient died of chronic disease, not the virus
MEXICO CITY (Reuters) - The Mexican resident identified with contracting A(H5N2) bird flu in Mexico died due to chronic diseases and not the virus, Mexico's health ministry said in a statement on Friday. Earlier this week, the World Health Organiza...
Jun 07, 2024